• Carr CM, Benson JC, DeLone DR, Diehn FE, Kim DK, Merrell KW, et al. Intracranial long-term complications of radiation therapy: an image-based review. Neuroradiology. 2021;63:471–82.

    Article 

    Google Scholar
     

  • Hijiya N, Hudson MM, Lensing S, Zacher M, Onciu M, Behm FG, et al. Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia. JAMA. 2007;297:1207–15.

    CAS 
    Article 

    Google Scholar
     

  • Minniti G, Traish D, Ashley S, Gonsalves A, Brada M. Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years. J Clin Endocrinol Metab. 2005;90:800–4.

    CAS 
    Article 

    Google Scholar
     

  • Paulino AC, Mai WY, Chintagumpala M, Taher A, Teh BS. Radiation-induced malignant gliomas: is there a role for reirradiation? Int J Radiat Oncol Biol Phys. 2008;71:1381–7.

    Article 

    Google Scholar
     

  • Yamanaka R, Hayano A, Kanayama T. Radiation-induced gliomas: a comprehensive review and meta-analysis. Neurosurg Rev. 2018;41:719–31.

    Article 

    Google Scholar
     

  • Neglia JP, Robison LL, Stovall M, Liu Y, Packer RJ, Hammond S, et al. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2006;98:1528–37.

    Article 

    Google Scholar
     

  • Taylor AJ, Little MP, Winter DL, Sugden E, Ellison DW, Stiller CA, et al. Population-based risks of CNS tumors in survivors of childhood cancer: the British Childhood Cancer Survivor Study. J Clin Oncol. 2010;28:5287–93.

    Article 

    Google Scholar
     

  • Pettorini BL, Park YS, Caldarelli M, Massimi L, Tamburrini G, Di Rocco C. Radiation-induced brain tumours after central nervous system irradiation in childhood: a review. Childs Nerv Syst. 2008;24:793–805.

    Article 

    Google Scholar
     

  • Hiraki T, Fukuoka K, Mori M, Arakawa Y, Matsushita Y, Hibiya Y, et al. Application of genome-wide DNA methylation analysis to differentiate a case of radiation-induced glioblastoma from late-relapsed medulloblastoma. J Neuropathol Exp Neurol. 2021;80:552–7.

    CAS 
    Article 

    Google Scholar
     

  • Izycka-Swieszewska E, Bien E, Stefanowicz J, Szurowska E, Szutowicz-Zielinska E, Koczkowska M, et al. Malignant gliomas as second neoplasms in pediatric cancer survivors: neuropathological study. Biomed Res Int. 2018;2018:4596812.

    Article 

    Google Scholar
     

  • Kajitani T, Kanamori M, Saito R, Watanabe Y, Suzuki H, Watanabe M, et al. Three case reports of radiation-induced glioblastoma after complete remission of acute lymphoblastic leukemia. Brain Tumor Pathol. 2018;35:114–22.

    Article 

    Google Scholar
     

  • Lopez GY, Van Ziffle J, Onodera C, Grenert JP, Yeh I, Bastian BC, et al. The genetic landscape of gliomas arising after therapeutic radiation. Acta Neuropathol. 2019;137:139–50.

    CAS 
    Article 

    Google Scholar
     

  • Nakao T, Sasagawa Y, Nobusawa S, Takabatake Y, Sabit H, Kinoshita M, et al. Radiation-induced gliomas: a report of four cases and analysis of molecular biomarkers. Brain Tumor Pathol. 2017;34:149–54.

    Article 

    Google Scholar
     

  • Deng MY, Sturm D, Pfaff E, Sill M, Stichel D, Balasubramanian GP, et al. Radiation-induced gliomas represent H3-/IDH-wild type pediatric gliomas with recurrent PDGFRA amplification and loss of CDKN2A/B. Nat Commun. 2021;12:5530.

    CAS 
    Article 

    Google Scholar
     

  • DeSisto J, Lucas JT Jr, Xu K, Donson A, Lin T, Sanford B, et al. Comprehensive molecular characterization of pediatric radiation-induced high-grade glioma. Nat Commun. 2021;12:5531.

    CAS 
    Article 

    Google Scholar
     

  • Cahan WG. Radiation-induced sarcoma–50 years later. Cancer. 1998;82:6–7.

    CAS 
    Article 

    Google Scholar
     

  • Cahan WG, Woodard HQ, et al. Sarcoma arising in irradiated bone; report of 11 cases. Cancer. 1948;1:3–29.

    CAS 
    Article 

    Google Scholar
     

  • Ohno M, Miyakita Y, Takahashi M, Igaki H, Matsushita Y, Ichimura K, et al. Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged >/= 75 years. Radiat Oncol. 2019;14:200.

    Article 

    Google Scholar
     

  • Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. WHO classification of tumours of the central nervous system. Revise 4th edition. Lyon: IARC Press; 2016.


    Google Scholar
     

  • Arita H, Narita Y, Matsushita Y, Fukushima S, Yoshida A, Takami H, et al. Development of a robust and sensitive pyrosequencing assay for the detection of IDH1/2 mutations in gliomas. Brain Tumor Pathol. 2015;32:22–30.

    CAS 
    Article 

    Google Scholar
     

  • Arita H, Yamasaki K, Matsushita Y, Nakamura T, Shimokawa A, Takami H, et al. A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas. Acta Neuropathol Commun. 2016;4:79.

    Article 

    Google Scholar
     

  • Arita H, Narita Y, Fukushima S, Tateishi K, Matsushita Y, Yoshida A, et al. Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss. Acta Neuropathol. 2013;126:267–76.

    CAS 
    Article 

    Google Scholar
     

  • Matsutani M, Kohno T, Nagashima T, Nagayama I, Matsuda T, Hoshino T, et al. Clinical trial of intravenous infusion of bromodeoxyuridine (BUdR) for radiosensitization of malignant brain tumors. Radiat Med. 1988;6:33–9.

    CAS 
    PubMed 

    Google Scholar
     

  • Ohno M, Narita Y, Miyakita Y, Okita Y, Matsushita Y, Yoshida A, et al. Histopathological malignant progression of grade II and III gliomas correlated with IDH1/2 mutation status. Brain Tumor Pathol. 2012;29:183–91.

    CAS 
    Article 

    Google Scholar
     

  • Bowers DC, Nathan PC, Constine L, Woodman C, Bhatia S, Keller K, et al. Subsequent neoplasms of the CNS among survivors of childhood cancer: a systematic review. Lancet Oncol. 2013;14:e321–8.

    Article 

    Google Scholar
     

  • Journy NMY, Zrafi WS, Bolle S, Fresneau B, Alapetite C, Allodji RS, et al. Risk factors of subsequent central nervous system tumors after childhood and adolescent cancers: findings from the french childhood cancer survivor study. Cancer Epidemiol Biomark Prev. 2021;30:133–41.

    CAS 
    Article 

    Google Scholar
     

  • Janss AJ, Mazewski C, Patterson B. Guidelines for treatment and monitoring of adult survivors of pediatric brain tumors. Curr Treat Options Oncol. 2019;20:10.

    Article 

    Google Scholar
     

  • Salvati M, D’Elia A, Melone GA, Brogna C, Frati A, Raco A, et al. Radio-induced gliomas: 20-year experience and critical review of the pathology. J Neurooncol. 2008;89:169–77.

    Article 

    Google Scholar
     

  • Fetcko K, Lukas RV, Watson GA, Zhang L, Dey M. Survival and complications of stereotactic radiosurgery: a systematic review of stereotactic radiosurgery for newly diagnosed and recurrent high-grade gliomas. Medicine (Baltimore). 2017;96: e8293.

    Article 

    Google Scholar
     

  • Shanker M, Chua B, Bettington C, Foote MC, Pinkham MB. Re-irradiation for recurrent high-grade gliomas: a systematic review and analysis of treatment technique with respect to survival and risk of radionecrosis. Neurooncol Pract. 2019;6:144–55.

    PubMed 

    Google Scholar
     

  • Cuneo KC, Vredenburgh JJ, Sampson JH, Reardon DA, Desjardins A, Peters KB, et al. Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys. 2012;82:2018–24.

    CAS 
    Article 

    Google Scholar
     

  • Whitehouse JP, Howlett M, Federico A, Kool M, Endersby R, Gottardo NG. Defining the molecular features of radiation-induced glioma: a systematic review and meta-analysis. Neurooncol Adv. 2021;3:vdab109.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • Rights and permissions

    Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

    Disclaimer:

    This article is autogenerated using RSS feeds and has not been created or edited by OA JF.

    Click here for Source link (https://www.biomedcentral.com/)